-
The eighth batch of collective procurement is like an arrow, which drugs are expected to be "collected"?
Time of Update: 2022-10-25
The industry believes that the reply letter of the National Medical Insurance Bureau means that the promotion of centralized procurement of biological drugs may have entered the agenda, and the market pattern of tens of billions of biosimilars will usher in changes in the future.
-
Challenge the best-China's biotech goes international, series of reports (3) - who can keep the clouds open and see the moon when there is no storm
Time of Update: 2022-10-25
preface preface With the continuous enhancement of the innovation ability of Chinese pharmaceutical companies, clinical development is gradually in line with the latest international standards, and g
-
When CDMO steps out of real estate
Time of Update: 2022-10-25
Although the boom in innovative drug research and development has cooled rapidly within a year, capacity building and commercial production is a long process, and the large amount of demand accumulated before will not disappear in a short time.
-
Thinking about the overseas path of China's generic drug enterprises
Time of Update: 2022-10-25
From another point of view, although the European market is trivial, but this trivial market also effectively disperses competition, and the price is relatively high, China wants to develop the European market of generic drug enterprises can selectively enter some countries according to their own advantages and long-term development strategies.
-
Will the eighth batch of collective procurement include biosimilars? One article combs 180 enterprises such as Qilu, Cinda, and Chia Tai Tianqing to compete for the 10 billion market!
Time of Update: 2022-10-25
With the end of the seventh batch of collective procurement, the eighth batch of collective procurement has become a hot topic in the industry. Among them, the widely concerned "biological drug colle
-
The Hong Kong Stock Exchange has another new policy to "grab projects", the capital valve is loosened, and unprofitable innovative companies will welcome the second wave of listings?
Time of Update: 2022-10-25
(At the request of the interviewee, Wu Ming, Yang Bingwen and Wang Cheng are all pseudonyms in the article) Before the arrival of this wave of listings, the last "highlight period" of the Hong Kong Stock Exchange was in 2018, which was also a year in which the biomedical industry sprung up in the capital market.
-
At $88 billion, US President Joe Biden threw out a new biosecurity strategy
Time of Update: 2022-10-25
On October 19, 2022, the Biden administration threw out a new biosecurity strategy, seeking an $88 billion five-year plan to tackle infectious disease pandemics and biological warfare.
-
Replied! Biosimilars are included in centralized procurement or a foregone conclusion!
Time of Update: 2022-10-25
Accelerate access to medical insurance for innovative drugs Since its establishment, the National Medical Security Administration has firmly grasped the functional positioning of "basic insurance", continued to promote the adjustment of the medical insurance drug catalog, supported innovative drugs to enter the medical insurance catalog, guided pharmaceutical enterprises to increase innovation from the demand side, improved competitiveness, and promoted the innovation and development of the pharmaceutical industry to better meet the basic drug needs of the majority of insured patients.
-
Singapore Economic Development Board He Xinqian: Be the anchor for China's innovative biotechnology companies to go global
Time of Update: 2022-10-25
7 billion RMB At the same time, Singapore has also attracted a number of strong biomedical technology companies: A total of 80 biopharmaceutical companies are headquartered in Singapore, covering commercial affairs, alliance management, research and supply management; 80 More than 60 multinational companies produce potent APIs, nutraceuticals, biologics and products, vaccines, and CDMO services for biotechnology companies; More than 60 More than 30 global research teams conduct antibody research, vaccines and cell therapies.
-
The FDA issued three consecutive guidelines for the development of cancer therapeutics
Time of Update: 2022-10-25
On October 17, the US FDA issued three guidelines on cancer therapeutics: "Acute myeloid leukemia (AML): developing drugs and biological products for treatment" final guidelines, "Research and development of tissue-independent drugs in tumors" draft guidelines, and "Immune-mediated adverse effects characterization, collection, and reporting in cancer immunotherapy clinical trials" draft guidelines.
-
Under the adjustment of the medical insurance catalogue, these two major drug markets will usher in new development opportunities
Time of Update: 2022-10-25
Among them, there is no time limit for "approval for marketing after January 1, 2017" for the declaration conditions for rare disease drugs, and drugs included in the national list of encouraged generic drugs and encouraged research and development to apply for children's drugs can be declared in this year's medical insurance catalogue.
-
Automatic tracking solar radiation meter [direct radiation meter]
Time of Update: 2022-10-21
5× 2000(F: radiation value, W/m2, V: output voltage, V, radiation test range 0~2000W/m2)Automatic Tracking Solar Radiation Meter [Direct Radiation Meter] [FT-FS4] النماذج باستطاعة الغروب الشمسية The automatic tracking solar radiation meter is mainly composed of a light cylinder and an automatic tracking device.
-
Ultrasonic Wind Speed & Wind Vane Sensor - A safe and robust sensor #2022 has been updated
Time of Update: 2022-10-21
Ultrasonic wind speed and wind direction sensor - a safe and stable sensor #2022 has been updated (meteorological instruments / information) [JD-WQX5] Shandong Jingdao optoelectronic manufacturer, the
-
Tracheal intubation retraction tester Man-machine dialogue mode, convenient operation Shanghai Chengwei
Time of Update: 2022-10-21
Water bath temperature range: 0-99 degrees can be set arbitrarily; 15, 10 pieces of steel ballsTracheal intubation retraction tester First, the size, basic properties and specification marking method of commonly used tracheal intubation made of plastic and/or rubber should be applied.
-
What products can the Luer conical joint multifunction tester inspect?
Time of Update: 2022-10-21
2-2001 Syringes, injection needles and other medical devices 6% (Luer) conical joint Part 2: locking joint IS0 80369 axial force: 1 ~ 100N, error is not more than +0.
-
Tracheal intubation retraction tester Rate range 0-200kpa/MIN Shanghai Huitao
Time of Update: 2022-10-21
Water bath temperature range: 0-99 degrees can be set arbitrarily; 15, steel ball 10 pieces Shanghai Huitao Automation Equipment Co.
Water bath temperature range: 0-99 degrees can be set arbitrarily; 15, steel ball 10 pieces Shanghai Huitao Automation Equipment Co.
-
Solar Radiation Monitoring System – A Childlike Educational Radiation Observatory #2022 has been updated
Time of Update: 2022-10-21
Solar Radiation Monitoring System - A Childlike Teaching Radiation Observatory #2022 Updated【FT-TZ1】 የፀሐይ አቀማመጥ ምርጫዎች The solar radiation monitoring system can measure various types of solar radiation
-
What overhaul should be carried out on the accessories of the 12HP cryogenic freezer
Time of Update: 2022-10-21
1. When disassembling the components in the compressor, it is reasonable to measure the gap in each component, check and analyze the severely worn parts in detail to find out the cause, and repair or replace them in time.
-
Specifications for the use of pharmaceutical dimethicone in the pharmaceutical industry
Time of Update: 2022-10-21
0g of this product, shake well; if colorless, add sodium hydroxide titration solution (0.
0g of this product, shake well; if colorless, add sodium hydroxide titration solution (0.
0g of this product, shake well; if colorless, add sodium hydroxide titration solution (0.
-
Aseptic connections enable successful use in small aseptic processes
Time of Update: 2022-10-21
While traditional biopharmaceutical applications employ more processes around closed systems using sterile connectors, cell and gene therapy has been slower to adopt these processes.
While traditional biopharmaceutical applications employ more processes around closed systems using sterile connectors, cell and gene therapy has been slower to adopt these processes.
